BELLUS Health Inc.: Istoricul versiunilor

29 septembrie 2024

• actualăprec 17:0829 septembrie 2024 17:08‎ 127.0.0.1 discuție‎ 1.203 octeți +12‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 15:4218 septembrie 2024 15:42‎ Admin discuție contribuții‎ 1.191 de octeți +1.191‎ Pagină nouă: Pagina dedicata companiei BELLUS Health Inc. listata cu simbolul US.BLU ==Descriere companie== BELLUS Health Inc. (www.bellushealth.com) is a clinical stage pharmaceutical company that is focused on developing a P2X3 antagonist to address various afferent hypersensitization-related disorders. The Company’s lead candidate, BLU-5937, is being studied in Phase II clinical trials in refractory chronic cough and chronic pruritus associated with atopic dermatitis. It is developi...